The Relationship Between Inflammatory Biomarkers and Symptom Distress in Lung Cancer Patients Undergoing Chemotherapy

Knowledge of the patterns of symptom distress in adults receiving treatment for lung cancer is an important first step in developing interventions that can potentially lessen symptom distress. The purposes of this secondary analysis were to describe the changes in patterns of symptom distress over time in adults receiving treatment for lung cancer, and to examine the relationship of selected demographic and clinical characteristics to symptom distress. Complete data were available for 117 patients. The patterns of symptom distress in adults receiving treatment for lung cancer varied between treatment groups and over time. Symptom distress scores were moderate to high on entry into the study, indicating that symptom management in newly diagnosed lung cancer patients is essential and should begin early in the course of illness. Moreover, clinical interventions should be tailored to the type of treatment. Various demographic and clinical variables were weak and inconsistent predictors of symptom distress, underscoring the importance of examining the role of psychosocial factors in mediating symptom distress.

Download Full-text

The Relationship Between Coagulation Tests and Stage in Lung Cancer Patients.

Acta Oncologica Turcica ◽

10.5505/aot.2019.48343 ◽

2019 ◽

Vol 52 (1) ◽

pp. 103-111

Author(s):

Sema Yılmaz Rakıcı ◽

Ozlem Terzi

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Lung Cancer Patients ◽

Coagulation Tests ◽

The Relationship

Download Full-text

1311P The role of inflammatory biomarkers in advanced non-small cell lung cancer patients treated with chemo-immunotherapy

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1913 ◽

2021 ◽

Vol 32 ◽

pp. S1010-S1011

Author(s):

E. Zattarin ◽

S. Manglaviti ◽

E. Galli ◽

G. Apollonio ◽

T. Beninato ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Inflammatory Biomarkers ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Relationship between Serum Bilirubin Level and the Prevalence of Lung Cancer in Smokers

10.21203/rs.3.rs-25846/v1 ◽

2020 ◽

Author(s):

Weilin Liu ◽

Tian Fu ◽

Le Wei ◽

Chun Liu ◽

Mohan Li

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Bilirubin Level ◽

Serum Bilirubin ◽

Serum Bilirubin Level ◽

Smoking History ◽

Retrospective Case ◽

Lung Cancer Patients ◽

Indirect Bilirubin ◽

The Relationship

Abstract Background The correlation between serum bilirubin level and multiple respiratory system diseases including lung cancer has been reported. We aimed to explore the relationship between serum bilirubin level and the prevalence of lung cancer among smokers in China. Methods We designed a retrospective case-control study and enrolled 266 lung cancer patients and 266 matched controls from The Third Xiangya Hospital of Central South University from February 2011 to May 2017. Data including diagnosis, serum bilirubin levels and smoking history were collected, which consistently showed significant differential in cases and controls. Results Lower total and indirect bilirubin level is correlated with smoking but they can be recuperating after cessation. The average bilirubin level in lung cancer patients was lower than matched controls. Low indirect bilirubin level within normal range is the risk factor of lung cancer in smokers (OR = 2.710). Of note, smokers whose serum bilirubin lower than 7.88 µmol / L has a higher risk of lung cancer in Chinese adults. Conclusions Serum indirect bilirubin level would be a screening predictor to identify higher risk smokers of lung cancer.

Download Full-text